Phase IIa Study of Nimotuzumab Plus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer With Wild Type K-ras.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Nimotuzumab (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- 11 Sep 2009 New trial record